Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (201)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (16)
2023 (30)
2022 (102)
2021 (32)
2020 (52)
2019 (59)
2018 (35)
2017 (51)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (10)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Results for "[search-keyword]"

Search

Sponsor content

492 result(s) found, displaying 311 to 320

GALANTAMINE AN SR galantamine (as hydrobromide) 8mg modified release capsules blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
OMEPRAZOLE GENERICHEALTH omeprazole 20 mg enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TRAMADOL AN SR tramadol hydrochloride 100 mg oral modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TRAMADOL AN SR tramadol hydrochloride 150 mg oral modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MORPHINE MR AN morphine sulfate pentahydrate 10 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
PREGABALIN LUPIN pregabalin 300 mg capsule blister pack (267567)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LUPIN pregabalin 300 mg capsule blister pack.
PREGABALIN APOTEX pregabalin 50 mg capsule blister pack (267553)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN APOTEX pregabalin 50 mg capsule blister pack.
PREGABALIN APOTEX pregabalin 100 mg capsule blister pack (267555)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN APOTEX pregabalin 100 mg capsule blister pack.
PREGABALIN APOTEX pregabalin 225 mg capsule blister pack (267558)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN APOTEX pregabalin 225 mg capsule blister pack.
PREGABALIN APOTEX pregabalin 200 mg capsule blister pack (267557)

14 February 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN APOTEX pregabalin 200 mg capsule blister pack.

Pages

First page
Previous page
…
Page 28
Page 29
Page 30
Page 31
Current page 32
Page 33
Page 34
Page 35
Page 36
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.